MRI contrast agent developer Epix Pharmaceuticals said that the shareholder class-action lawsuit filed against the firm has been dismissed.
Judge Patti Saris of the U.S. District Court for the District of Massachusetts granted the Cambridge, MA-based firm's motion to dismiss for failure to prosecute the lawsuit. The dismissal was issued without prejudice, Epix said.
By AuntMinnie.com staff writers
February 2, 2006
Related Reading
Epix to accelerate EP-2104R phase IIa trials, January 4, 2006
Epix hires consulting firm for acquisition analysis, December 16, 2005
Epix to slash workforce next month, December 14, 2005
Epix hit with Vasovist setback, November 23, 2005
Schering, Epix score European approval for Vasovist, October 5, 2005
Copyright © 2006 AuntMinnie.com